Amyloid-β42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis
- 227 Downloads
Sporadic inclusion-body myositis (s-IBM) is the only muscle disease in which accumulation of amyloid-β (Aβ) in abnormal muscle fibers appears to play a key pathogenic role. Increased amyloid-β precursor protein (AβPP) and Aβ accumulation have been reported to be upstream steps in the development of the s-IBM pathologic phenotype, based on cellular and animal models. Aβ is released from AβPP as a 40 or 42 aminoacid peptide. Aβ42 is considered more cytotoxic than Aβ40, and it has a higher propensity to aggregate and form amyloid fibrils. Using highly specific antibodies, we evaluated in s-IBM muscle biopsies intra-muscle fiber accumulation of Aβ40 and Aβ42-immunoreactive aggregates by light- and electron-microscopic immunocytochemistry, and quantified their amounts by ELISA. In s-IBM, 80–90% of the vacuolated muscle fibers and 5–20% of the non-vacuolated muscle fibers contained plaque-like Aβ42-immunoreactive inclusions, while only 69% of those fibers also contained Aβ40 deposits. By immuno-electronmicroscopy, Aβ42 was associated with 6–10 nm amyloid-like fibrils, small electron-dense floccular clumps and larger masses of amorphous material. Aβ40 was present only on small patches of floccular clumps and amorphous material; it was not associated with 6–10 nm amyloid fibrils. By ELISA, in s-IBM muscle biopsies Aβ42 was present in values 8.53-44.7 pg/ml, while Aβ40 was not detectable; normal age-matched control biopsies did not have any detectable Aβ42 or Aβ40. Thus, in s-IBM muscle fibers, Aβ42 is accumulated more than Aβ40. We suggest that Aβ42 oligomers and their cytotoxicity may play an important role in the s-IBM pathogenesis.
KeywordsInclusion-body myositis Amyloid-β42 Amyloid-β40 Amyloid-β Amyloid-β oligomers Cytotoxicity
Dr. Vattemi’s current address is Clinica Neurologica, Policlinico G.B. Rossi, Via Delle Menegone 10, I-37134 Verona, Italy. Dr. Nogalska is on leave from Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland. Maggie Baburyan provided excellent technical assistance in electronmicroscopy.
- 5.Askanas V, Engel WK, Yang CC, Alvarez RB, Lee VM, Wisniewski T (1998) Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy. Am J Pathol 152:889–895PubMedGoogle Scholar
- 8.Barelli H, Lebeau A, Vizzavona J, Delaere P, Chevallier N, Drouot C et al (1997) Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer’s disease and cerebral amyloid angiopathy cases. Mol Med 3:695–707PubMedGoogle Scholar
- 22.Mirabella M, Alvarez RB, Bilak M, Engel WK, Askanas V (1996) Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies. J Neuropathol Exp Neurol 55:774–786. doi: 10.1097/00005072-199607000-00003 PubMedCrossRefGoogle Scholar
- 24.Nogalska A, Engel WK, McFerrin J, Kokame K, Komano H, Askanas V (2006) Homocysteine-induced endoplasmic reticulum protein (Herp) is up-regulated in sporadic inclusion-body myositis and in endoplasmic reticulum stress-induced cultured human muscle fibers. J Neurochem 96:1491–1499. doi: 10.1111/j.1471-4159.2006.03668.x PubMedCrossRefGoogle Scholar
- 25.Oddo S, Caccamo A, Tseng B, Vasilevko V, Cribs DH et al (2008) Blocking Abeat42 accumumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology. J Neurosci 28:12163–12175. doi: 10.1523/JNEUROSCI.2464-08.2008 PubMedCrossRefGoogle Scholar
- 27.Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat Med 2:864–870. doi: 10.1038/nm0896-864 PubMedCrossRefGoogle Scholar
- 32.Vattemi G, Kefi M, Engel WK, Askanas V (2003) Nicastrin, a novel protein participating in amyloid-b production, is overexpressed in sporadic inclusion-body myositis muscle. Neurology 60:A315Google Scholar
- 36.Yanker BA, Lu T (2008) Amyloid β-protein toxicity and the pathogenesis of Alzheimer’s disease. J Biol Chem doi: 10.1074/jbc.R800018200